Announcements Trials
Browse Landscape

Phase

Phase 1 6Phase 2 2

Status

Recruiting 4Terminated 2Completed 1Active not recruiting 1

Sponsor Class

OTHER 8NIH 1

Study Type

Interventional 8

Sponsor

Cancer Type

CNS 6Sarcoma 1Gynecologic 1Dermatologic 1

Conditions

Brain Neoplasms 3Medulloblastoma 2Glioma 2Diffuse Intrinsic Pontine Glioma 2Xanthomatosis, Cerebrotendinous 1Recurrence 1Oligodendroglioma 1Melanoma 1Influenza, Human 1Advanced Fallopian Tube Carcinoma 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

8 trials
RecentStart dateEnrollment
OTHER × Diphtheria-Tetanus Vaccine × Clear all
NCT06254326 2026-05-27

ADAGiO

University of Florida

Phase 1 Recruiting
12 enrolled
CNS

Brain Neoplasms, Oligodendroglioma

NCT05096481 2026-05-11

PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma

Nationwide Children's Hospital

Phase 2 Recruiting
120 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Glioma, Medulloblastoma

NCT03334305 2026-04-23

ACTION

University of Florida

Phase 1 Terminated
18 enrolled 11 charts
CNS

Glioma

NCT06514898 2026-04-03

MATCHPOINT

University of Florida

Phase 1 Active not recruiting
12 enrolled
CNS

Medulloblastoma

NCT03396575 2025-10-29

BRAVO

University of Florida

Phase 1 Terminated
11 enrolled
CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Influenza, Human, Xanthomatosis, Cerebrotendinous

NCT06639074 2025-10-02

Folate Receptor Alpha Dendritic Cells (FRαDCs) or Placebo for the Treatment of Patients With Stage III or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, FAROUT Trial

Mayo Clinic

Phase 2 Recruiting
78 enrolled
GynecologicSarcoma

Advanced Fallopian Tube Carcinoma

NCT05077137 2025-08-27

TdVax

Duke University

Phase 1 Recruiting
25 enrolled
Dermatologic

Melanoma

NCT02193347 2023-12-01

RESIST

Duke University

Phase 1 Completed
24 enrolled 8 charts
CNS

Brain Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡